141 related articles for article (PubMed ID: 19065654)
1. SRPX2 is overexpressed in gastric cancer and promotes cellular migration and adhesion.
Tanaka K; Arao T; Maegawa M; Matsumoto K; Kaneda H; Kudo K; Fujita Y; Yokote H; Yanagihara K; Yamada Y; Okamoto I; Nakagawa K; Nishio K
Int J Cancer; 2009 Mar; 124(5):1072-80. PubMed ID: 19065654
[TBL] [Abstract][Full Text] [Related]
2. Impact of overexpression of Sushi repeat-containing protein X-linked 2 gene on outcomes of gastric cancer.
Yamada T; Oshima T; Yoshihara K; Sato T; Nozaki A; Shiozawa M; Ota M; Yoshikawa T; Akaike M; Numata K; Rino Y; Kunisaki C; Tanaka K; Imada T; Masuda M
J Surg Oncol; 2014 Jun; 109(8):836-40. PubMed ID: 24700475
[TBL] [Abstract][Full Text] [Related]
3. SRPX2 promotes cell migration and invasion via FAK dependent pathway in pancreatic cancer.
Gao Z; Zhang J; Bi M; Han X; Han Z; Wang H; Ou Y
Int J Clin Exp Pathol; 2015; 8(5):4791-8. PubMed ID: 26191169
[TBL] [Abstract][Full Text] [Related]
4. SRPX2, an independent prognostic marker, promotes cell migration and invasion in hepatocellular carcinoma.
Lin X; Chang W; Wang Y; Tian M; Yu Z
Biomed Pharmacother; 2017 Sep; 93():398-405. PubMed ID: 28654796
[TBL] [Abstract][Full Text] [Related]
5. Increased Sushi repeat-containing protein X-linked 2 is associated with progression of colorectal cancer.
Liu KL; Wu J; Zhou Y; Fan JH
Med Oncol; 2015 Apr; 32(4):99. PubMed ID: 25737434
[TBL] [Abstract][Full Text] [Related]
6. Sushi repeat-containing protein X-linked 2 promotes angiogenesis through the urokinase-type plasminogen activator receptor dependent integrin αvβ3/focal adhesion kinase pathways.
Liu K; Fan J; Wu J
Drug Discov Ther; 2017; 11(4):212-217. PubMed ID: 28867754
[TBL] [Abstract][Full Text] [Related]
7. SRPX2 Promotes Tumor Proliferation and Migration via the FAK Pathway in Papillary Thyroid Carcinoma.
Luo N; Tan Y; Deng H; Wu W; Mei L; Huang X; Qin Y; Zhu H; Liu C
J Oncol; 2022; 2022():5821545. PubMed ID: 36385962
[TBL] [Abstract][Full Text] [Related]
8. Silencing profilin-1 inhibits gastric cancer progression via integrin β1/focal adhesion kinase pathway modulation.
Cheng YJ; Zhu ZX; Zhou JS; Hu ZQ; Zhang JP; Cai QP; Wang LH
World J Gastroenterol; 2015 Feb; 21(8):2323-35. PubMed ID: 25741138
[TBL] [Abstract][Full Text] [Related]
9. NAIF1 inhibits gastric cancer cells migration and invasion via the MAPK pathways.
Yang M; Gu YY; Peng H; Zhao M; Wang J; Huang SK; Yuan XH; Li J; Sang JL; Luo Q; Huang C
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1037-47. PubMed ID: 25432142
[TBL] [Abstract][Full Text] [Related]
10. CEACAM6 promotes tumor angiogenesis and vasculogenic mimicry in gastric cancer via FAK signaling.
Zang M; Zhang Y; Zhang B; Hu L; Li J; Fan Z; Wang H; Su L; Zhu Z; Li C; Yan C; Gu Q; Liu B; Yan M
Biochim Biophys Acta; 2015 May; 1852(5):1020-8. PubMed ID: 25703140
[TBL] [Abstract][Full Text] [Related]
11. LEFTY2 Controls Migration of Human Endometrial Cancer Cells via Focal Adhesion Kinase Activity (FAK) and miRNA-200a.
Alowayed N; Salker MS; Zeng N; Singh Y; Lang F
Cell Physiol Biochem; 2016; 39(3):815-26. PubMed ID: 27497669
[TBL] [Abstract][Full Text] [Related]
12. SRPX2 Enhances the Epithelial-Mesenchymal Transition and Temozolomide Resistance in Glioblastoma Cells.
Tang H; Zhao J; Zhang L; Zhao J; Zhuang Y; Liang P
Cell Mol Neurobiol; 2016 Oct; 36(7):1067-76. PubMed ID: 26643178
[TBL] [Abstract][Full Text] [Related]
13. SRPX2 knockdown inhibits cell proliferation and metastasis and promotes chemosensitivity in esophageal squamous cell carcinoma.
He F; Wang H; Li Y; Liu W; Gao X; Chen D; Wang Q; Shi G
Biomed Pharmacother; 2019 Jan; 109():671-678. PubMed ID: 30551519
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
[TBL] [Abstract][Full Text] [Related]
15. Sushi repeat-containing protein X-linked 2: A novel phylogenetically conserved hypothalamo-pituitary protein.
Anwer M; Bolkvadze T; Ndode-Ekane XE; Puhakka N; Rauramaa T; Leinonen V; van Vliet EA; Swaab DF; Haapasalo A; Leskelä S; Bister N; Malm T; Carlson S; Aronica E; Pitkänen A
J Comp Neurol; 2018 Aug; 526(11):1806-1819. PubMed ID: 29663392
[TBL] [Abstract][Full Text] [Related]
16. SRPX2 Promotes Cell Proliferation and Invasion in Osteosarcoma Through Regulating Hippo Signaling Pathway.
Wu Z; Wang C; Chen Y; Sun Z; Yan W
Onco Targets Ther; 2020; 13():1737-1749. PubMed ID: 32161469
[TBL] [Abstract][Full Text] [Related]
17. SRPX2 is a novel chondroitin sulfate proteoglycan that is overexpressed in gastrointestinal cancer.
Tanaka K; Arao T; Tamura D; Aomatsu K; Furuta K; Matsumoto K; Kaneda H; Kudo K; Fujita Y; Kimura H; Yanagihara K; Yamada Y; Okamoto I; Nakagawa K; Nishio K
PLoS One; 2012; 7(1):e27922. PubMed ID: 22242148
[TBL] [Abstract][Full Text] [Related]
18. Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling.
Wangpu X; Lu J; Xi R; Yue F; Sahni S; Park KC; Menezes S; Huang ML; Zheng M; Kovacevic Z; Richardson DR
Mol Pharmacol; 2016 May; 89(5):521-40. PubMed ID: 26895766
[TBL] [Abstract][Full Text] [Related]
19. Collagen type I regulates beta-catenin tyrosine phosphorylation and nuclear translocation to promote migration and proliferation of gastric carcinoma cells.
Li A; Zhou T; Guo L; Si J
Oncol Rep; 2010 May; 23(5):1247-55. PubMed ID: 20372837
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of L1CAM is associated with tumor progression and prognosis via ERK signaling in gastric cancer.
Ito T; Yamada S; Tanaka C; Ito S; Murai T; Kobayashi D; Fujii T; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
Ann Surg Oncol; 2014 Feb; 21(2):560-8. PubMed ID: 24046108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
